CSIMarket



Bristol myers Squibb Company  (BMY)
Other Ticker:  
 
 

BMY's Revenue Growth by Quarter and Year

Bristol Myers Squibb's Revenue results by quarter and year




BMY Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 11,985.00 11,068.00 7,945.00
III Quarter September - 11,624.00 10,540.00 6,007.00
II Quarter June - 11,703.00 10,129.00 6,273.00
I Quarter March 11,648.00 11,073.00 10,781.00 5,920.00
FY   11,648.00 46,385.00 42,518.00 26,145.00



BMY Revenue first quarter 2022 Y/Y Growth Comment
Bristol myers Squibb Company achieved in the first quarter 2022, above Company average Revenue improvement of 5.19% year on year, to $ 11,648.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 6 other companies have achieved higher Revenue growth. While Bristol Myers Squibb Company' s Revenue increase of 5.19% ranks overall at the positon no. 419 in the first quarter 2022.




BMY Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 8.29 % 39.31 % 33.02 %
III Quarter September - 10.28 % 75.46 % 5.55 %
II Quarter June - 15.54 % 61.47 % 9.98 %
I Quarter March 5.19 % 2.71 % 82.11 % 14 %
FY   - 9.09 % 62.62 % 15.89 %

Financial Statements
Bristol Myers Squibb's first quarter 2022 Revenue $ 11,648.00 millions BMY's Income Statement
Bristol Myers Squibb's first quarter 2021 Revenue $ 11,073.00 millions Quarterly BMY's Income Statement
New: More BMY's historic Revenue Growth >>


BMY Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 3.11 % 5.01 % 32.26 %
III Quarter September - -0.68 % 4.06 % -4.24 %
II Quarter June - 5.69 % -6.05 % 5.96 %
I Quarter March -2.81 % 0.05 % 35.7 % -0.89 %
FY (Year on Year)   - 9.09 % 62.62 % 15.89 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #32
Overall #419

Revenue Y/Y Growth Statistics
High Average Low
18.59 % 1.29 % -8.06 %
(Mar 31 2020)   (March 31, 2013)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #32
Overall #419
Revenue Y/Y Growth Statistics
High Average Low
18.59 % 1.29 % -8.06 %
(Mar 31 2020)   (March 31, 2013)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Bristol Myers Squibb's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
35.7 % 1.49 % -15.91 %
(Mar 31 2020)  


BMY's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Bristol Myers Squibb Company reported fall in Revenue from the forth quarter by -2.81% to $ 11,648.00 millions, from $ 11,985.00 millions released in the previous quarter.

Although seasonal factors normally energize I. Quarter 2022 Revenue, it plainly has not been sufficient to salvage BMY's performance, Rodrigo Marques, market advisor from Lisbon pointed out.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 384.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #33
Overall #384
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #33
Overall #384
Revenue Q/Q Growth Statistics
High Average Low
35.7 % 1.49 % -15.91 %
(Mar 31 2020)  


BMY's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Bristol Myers Squibb Company reported fall in Revenue from the previous quarter by -2.81% to $ 11,648.00 millions, from $ 11,985.00 millions released in the previous quarter.

Even cyclical factors which commonly energize I. Quarter 2022 results, it plainly was not sufficient to rescue Bristol Myers Squibb's I. Quarter performance, Rodrigo Marques, market advisor from Lisbon said.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 384.


Bristol Myers Squibb's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 46,960.00 $ 46,385.00 $ 45,468.00 $ 44,384.00 $ 42,810.00
Y / Y Revenue Growth (TTM) 9.69 % 9.09 % 15.42 % 27.31 % 38.07 %
Year on Year Revenue Growth Overall Ranking # 2285 # 335 # 1703 # 74 # 45
Seqeuential Revenue Change (TTM) 1.24 % 2.02 % 2.44 % 3.68 % 0.69 %
Seq. Revenue Growth (TTM) Overall Ranking # 2305 # 665 # 2335 # 241 # 2407




Cumulative Revenue growth Comment
Bristol Myers Squibb saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.69% year on year, to $ 46,960 millions if the fiscal year would have ended in Mar 31 2022.
Bristol Myers Squibb's trailing twelve months Revenue growth was higher than company's average 6.3% and higher than 9.09% growth in Dec 31 2021.
But from the previous reporting period increase was less at 1.24 % from $46385 millions achieved in the period from Dec 31 2021 to Mar 31 2021 Rodrigo Marques went on.
There is drop-off happening, more evident if you pay attention to the usual Q/Q TTM Revenue increase what is better at1.29%.
The progress was much stronger sequentially showed at 1.24 % rise from $46385 millions in the period from Dec 31 2021 to Mar 31 2021.

In the Healthcare sector 321 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 335 to 2285.

Revenue TTM Q/Q Growth Statistics
High Average Low
18.59 %
1.29 %
-8.06 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 112
Healthcare Sector # 322
Overall # 2285

Revenue TTM Y/Y Growth Statistics
High Average Low
62.97 %
6.3 %
-24.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 112
Sector # 349
S&P 500 # 2305
Cumulative Revenue growth Comment
Bristol Myers Squibb saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.69% year on year, to $ 46,960 millions if the fiscal year would have ended in Mar 31 2022.
Bristol Myers Squibb's trailing twelve months Revenue growth was higher than company's average 6.3% and higher than 9.09% growth in Dec 31 2021.
But sequential increase was slower at 1.24 % from $46385 millions reported in twelve months ending a quarter Dec 31 2021.
We witness drop-off developing, more obvious if you pay attention to the typical sequential Revenue rise that is higher at 1.29%.
The momentum is even stronger sequentially clinched at 1.24 % jump from $46385 millions in twelve months ending a quarter before.

In the Healthcare sector 321 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 335 to 2285.

Revenue TTM Q/Q Growth Statistics
High Average Low
18.59 %
1.29 %
-8.06 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 112
Healthcare Sector # 322
Overall # 2285

Revenue TTM Y/Y Growth Statistics
High Average Low
62.97 %
6.3 %
-24.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 112
Sector # 349
S&P 500 # 2305




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BMY's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BMY's Competitors
Revenue Growth for Bristol Myers Squibb's Suppliers
Revenue Growth for BMY's Customers

You may also want to know
BMY's Annual Growth Rates BMY's Profitability Ratios BMY's Asset Turnover Ratio BMY's Dividend Growth
BMY's Roe BMY's Valuation Ratios BMY's Financial Strength Ratios BMY's Dividend Payout Ratio
BMY's Roa BMY's Inventory Turnover Ratio BMY's Growth Rates BMY's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Lhc Group Inc8.89%$ 8.890 millions
Align Technology inc 8.77%$ 8.767 millions
Henry Schein Inc 8.69%$ 8.685 millions
Sunlink Health Systems Inc.8.61%$ 8.611 millions
Intercept Pharmaceuticals inc 8.48%$ 8.475 millions
Berkeley Lights Inc 8.47%$ 8.471 millions
National Research Corporation8.39%$ 8.394 millions
Encompass Health Corporation8.39%$ 8.388 millions
Acadia Pharmaceuticals Inc 8.37%$ 8.366 millions
10x Genomics Inc 8.20%$ 8.198 millions
Stryker Corp8.15%$ 8.146 millions
Mednax Inc 7.94%$ 7.941 millions
Nature s Sunshine Products inc 7.88%$ 7.882 millions
The Pennant Group Inc 7.81%$ 7.805 millions
Pacific Health Care Organization Inc.7.78%$ 7.779 millions
Procyon Corp7.64%$ 7.644 millions
Idexx Laboratories Inc7.57%$ 7.566 millions
Sangamo Therapeutics Inc 7.42%$ 7.424 millions
West Pharmaceutical Services Inc 7.35%$ 7.351 millions
Cytomx Therapeutics Inc 7.29%$ 7.294 millions
Bruker Corporation7.27%$ 7.265 millions
Msa Safety Inc7.22%$ 7.219 millions
Nuvasive Inc7.19%$ 7.194 millions
Heska Corporation7.10%$ 7.102 millions
Anika Therapeutics Inc 7.00%$ 7.002 millions
Sigilon Therapeutics Inc 7.00%$ 6.998 millions
Hca Healthcare Inc 6.93%$ 6.926 millions
Biomarin Pharmaceutical Inc6.86%$ 6.857 millions
Rackspace Technology Inc 6.83%$ 6.833 millions
Neurometrix Inc 6.82%$ 6.816 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TGI's Profile

Stock Price

TGI's Financials

Business Description

Fundamentals

Charts & Quotes

TGI's News

Suppliers

TGI's Competitors

Customers & Markets

Economic Indicators

TGI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071